With US futures trading limit down, most stocks are trading lower. The following represents mostly stocks with specific catalysts
Gapping down
In reaction to disappointing earnings/guidance:
- FANG -25.8% (cut guidance and operations), SOHU -2.7%, KLXE -0.8%, ANAB -0.6%
Select ETFs showing weakness:
- XLE -17.1%, XLF -8.6%, XLI -7.5%, IWM -7.3%, XLK -7.2%, SPY -6.4%, DIA -6.4%, QQQ -6%
Select oil/gas related names showing early weakness:
- HAL -23.8%, USO -23.3%, SLB -22.6%, BP -19.7%, XOM -14.3%, RDS.A -13.2%, TOT -12.1%, PSX -9.1%
Other news:
- OVV -34.3% (files mixed securities shelf offering)
- DVN -28.6% (files mixed securities shelf offering)
- BMY -7% (after topline results from ELOQUENT-1 did not meet primiary endpoint)
- AYX -6.8% (postpones Analyst Day previously scheduled for March 10, citing COVID-19 concerns)
- ARDX -4.2% (says it's on-track to submit NDA for Tenapanor for the control of serum phosphorus in mid-2020)
Analyst comments:
- BUD -5.2% (downgraded to Neutral from Outperform at Credit Suisse)
- GILD -3.1% (downgraded to Outperform from Top Pick at RBC Capital Mkts)